Publications by authors named "Katalin Csige"

Claim this Profile
I
In vivo assessment of tumor targeting potential of Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-β-cyclodextrin (HPβCD) using positron emission tomography.
Judit P Szabó, Katalin Csige, Ibolya Kálmán-Szabó, Viktória Arató, Gábor Opposits

Int J Pharm· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice.
Katalin Csige, Judit P Szabó, Ibolya Kálmán-Szabó, Noémi S Dénes, Dezső Szikra

Int J Pharm· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo preclinical evaluation of the new Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography.
György Trencsényi, Adrienn Kis, Judit P Szabó, Ágnes Ráti, Katalin Csige

Int J Pharm· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis